The Department of War (DoW) is required by law (10 U.S.C. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoW Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoW Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ.
P&T COMMITTEE MEETING: The following February 2027 drug classes/subclasses will be reviewed:
a. Ophthalmic - Dry Eye
Cequa
Eysuvis
Miebo
Tryptyr
Tyrvaya
Verkazia
Vevye
Xiidra
b. Testosterone Replacement Therapy - Orals
Jatenzo
Kyzatrex
Tlando
The RFQ, including UF BPA and UF ADP appendices, are attached herein. The instructions, important deadlines, and points of contact are in document, RFQ HT9402-27-Q-9101. Pre-quotation teleconference is on November 17, 2026. Details are stated in Part 2.4. Pre-Quotation Teleconference.
Pharmaceutical manufacturers are to submit price quotes for the UF BPA (for Military Treatment Facilities and the TRICARE Mail Order Pharmacy) and/or refund quotes for the UF ADP (for the TRICARE retail network) for specific drug classes (Ophthalmic - Dry Eye and Testosterone Replacement Therapy - Orals) being reviewed by the DoW Pharmacy and Therapeutics (P&T) Committee. The quotes will be evaluated based on clinical effectiveness and cost effectiveness to recommend placement on the Uniform Formulary and cost-share tier classification.
We post new medical & laboratory opportunities in Texas as agencies publish them. Get them in one email — free, and unsubscribe whenever.
"80011""AURORA""CO""USA""MANAGED CARE CONTRACT DIRECTORATE""ATTN: AEA""RFQ HT9402-27-Q-9101.pdf"947614"file"".pdf""1""2026-11-12T19:46:20.447+00:00""6bc8ee29bed245eeaaff66f3cbcc746e""public""0""public""43fe0161efdf420c95f72354b2564c16""0"25"0""PL - Ophthalmic - Dry Eye.xlsx"45530"file"".xlsx""1""2026-11-12T19:46:20.447+00:00""36bab3419e4846fe8732bc726efb94ec""public""0""public""feaa0920b878431692041faacbaadee4""0"18"0""PL - Testosterone Replacement Therapy - Orals.xlsx"45870"file"".xlsx""1""2026-11-12T19:46:20.447+00:00""40e75a990635445ba3e6d019a4069742""public""0""public""616e6fbce4d54cce887ffb4679e7ad73""0"11"0""FAR 52-225-6-Certificate.pdf"660670"file"".pdf""1""2026-11-12T19:46:20.447+00:00""7a62a45dcd734eabbdcd018fbf9cc62b""public""0""public""120ac6c63ef94e46a94336ccaacf8551""0"8"0""Feb 2027 PandT Meeting Reporting.xlsx"194249"file"".xlsx""1""2026-11-12T19:46:20.447+00:00""2e11794c620443ff93424d76cdc03355""public""0""public""43a970ade84d4275a3426dcb50b70c22""0"7"0""NDC Price List FAQ Class Review.pdf"232281"file"".pdf""1""2026-11-12T19:46:20.447+00:00""db2c1e5136de4db2add46d6972ef3f68""public""0""public""8c8ab29d51984bfbb92feda16d44c273""0"6"0""http://health.mil/PandT""http://health.mil/PandT"0"link""1""2026-11-12T19:46:20.447+00:00""b593414d0cf14e61ac947dc2dd7c89b5""public""0""http://health.mil/PandT""public""7a4a723de6cc4340aefbcb0d99eb97ef""0"1"0"Most Texas work asks for the two below, and the solicitation documents are where it’s stated. One prequalification covers both — on this bid and the next.
A surety’s written statement that it expects to bond you up to a stated amount, subject to final underwriting. It’s what an agency asks to see before they take your bid seriously.
Source: SAM.gov (notice 4379b35024844e9e8afaa128b80b3809), retrieved via the SAM.gov Get Opportunities API. View the official posting, and always confirm requirements and deadlines with the issuing agency.